The 'Difficult Conversations' About Delaying Breast Reconstruction Surgery During the COVID-19 Pandemic

Video

Patients with breast cancer have come to terms that the risks of having reconstructive surgery at this time are too great, according to one expert.

When women receive a breast cancer diagnosis and hear that they will need a mastectomy — removal of one of both breasts — to treat their disease, many feel that they will be losing a part of their identity and look to schedule reconstructive plastic surgery to regain a part of that identity as soon as possible.

However, as the novel coronavirus has spread across the world, all elective surgeries, including breast reconstruction, have been delayed. And although many patients have been understanding about the delays, Dr. Jonathan Bank, a board-certified plastic surgeon at New York Breast Reconstruction and Aesthetic (NYBRA) Plastic Surgery, says it still has been a difficult conversation.

“For the most part, people have been very understanding,” Bank, who specializes in breast reconstruction after cancer, said in an interview with CURE® “No one is really blind to what is going on right now. It has been very stressful and saddening giving news to patients that they couldn't have surgery at this point; that's probably been one of the most difficult components for us, but they are all understanding. They know that in the balance of risks and benefits, the risks of having surgery at this point are too great.”

Bank said that even though surgeries have been delayed, he still has been communicating directly with patients either through text messaging or via phone calls to see how they are doing. Bank noted that not only has the open communication been helpful for his patients, but for him as well.

“I’ve been in medicine for 25 years ... and it's a huge part of my life, and not being able to do what I do is a little bit disorienting,” he said. “For me, it’s been very nice to provide remote consultations even though some things may be very theoretical at this point because … but I think just giving people some hope that there is a light at the end of yet another tunnel and we’re there at the other end hopefully.”

Related Videos
Image of Kristen Dahlgren at Extraordinary Healer.
Jessica McDade, B.S.N., RN, OCN, in an interview with CURE
Image of a woman with short blonde hair wearing a white blazer.
For patients with cancer, the ongoing chemotherapy shortage may cause some anxiety as they wonder how they will receive their drugs. However, measuring drugs “down to the minutiae of the milligrams” helped patients receive the drugs they needed, said Alison Tray. Tray is an advanced oncology certified nurse practitioner and current vice president of ambulatory operations at Rutgers Cancer Institute in New Jersey.  If patients are concerned about getting their cancer drugs, Tray noted that having “an open conversation” between patients and providers is key.  “As a provider and a nurse myself, having that conversation, that reassurance and sharing the information is a two-way conversation,” she said. “So just knowing that we're taking care of you, we're going to make sure that you receive the care that you need is the key takeaway.” In June 2023, many patients were unable to receive certain chemotherapy drugs, such as carboplatin and cisplatin because of an ongoing shortage. By October 2023, experts saw an improvement, although the “ongoing crisis” remained.  READ MORE: Patients With Lung Cancer Face Unmet Needs During Drug Shortages “We’re really proud of the work that we could do and achieve that through a critical drug shortage,” Tray said. “None of our patients missed a dose of chemotherapy and we were able to provide that for them.” Tray sat down with CURE® during the 49th Annual Oncology Nursing Society Annual Congress to discuss the ongoing chemo shortage and how patients and care teams approached these challenges. Transcript: Particularly at Hartford HealthCare, when we established this infrastructure, our goal was to make sure that every patient would get the treatment that they need and require, utilizing the data that we have from ASCO guidelines to ensure that we're getting the optimal high-quality standard of care in a timely fashion that we didn't have to delay therapies. So, we were able to do that by going down to the minutiae of the milligrams on hand, particularly when we had a lot of critical drug shortages. So it was really creating that process to really ensure that every patient would get the treatment that they needed. For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.
Image of a woman with black hair.
Image of a woman with brown shoulder-length hair in front of a gray background that says CURE.